Glucuronidation of Drugs by Hepatic Microsomes Derived from Healthy and Cirrhotic Human Livers
- 1 May 1999
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 289 (2) , 1169-1175
- https://doi.org/10.1016/s0022-3565(24)38249-7
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- Predicting the hepatic clearance of xenobiotics in humans fromin vitro dataBiopharmaceutics & Drug Disposition, 1994
- Is glucuronidation truly preserved in patients with liver disease?Hepatology, 1991
- Glucuronidation of Oxazepam Is Not Spared in Patients With Hepatic EncephalopathyHepatology, 1990
- Properties of human hepatic UDP-glucuronosyltransferases. Relationship to other inducible enzymes in patients with cholestasisEuropean Journal of Clinical Pharmacology, 1987
- Abnormal Glucuronidation of Zomepirac in Patients with Cirrhosis of the LiverHepatology, 1983
- Pharmacokinetics of coumarin and its 7-hydroxy-metabolites upon intravenous and peroral administration of coumarin in manEuropean Journal of Clinical Pharmacology, 1977
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- Determination of Coumarin and Umbelliferone Mixtures in Whole Blood by SpectrophotofluorometryJournal of Pharmaceutical Sciences, 1976
- Transection of the oesophagus for bleeding oesophageal varicesBritish Journal of Surgery, 1973
- Clearance concepts in pharmacokineticsJournal of Pharmacokinetics and Biopharmaceutics, 1973